Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-23-000018
Filing Date
2023-01-09
Accepted
2023-01-09 17:09:24
Documents
1
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167330214981696.html 4  
1 FORM 4 wf-form4_167330214981696.xml 4 3277
  Complete submission text file 0001385508-23-000018.txt   4828
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 464744124 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 445 PARK AVE 10TH FL. NEW YORK NY 10022
Business Address
CRYSTAL ROGER (Reporting) CIK: 0001656633 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 23518838